<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="15358">Histones</z:chebi> are known to bind anionic <z:chebi fb="1" ids="16247">phospholipids</z:chebi> (PLs) </plain></SENT>
<SENT sid="1" pm="."><plain>Binding of procoagulant PLs by <z:chebi fb="0" ids="15358">histones</z:chebi> released during cell injury/<z:hpo ids='HP_0011420'>death</z:hpo> may interfere with coagulation and may serve a local regulatory <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> function </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="15358">Histone</z:chebi> H1 prolonged the PT and APTT of <z:mpath ids='MPATH_458'>normal</z:mpath> pooled plasma (<z:chebi fb="33" ids="7468">NPP</z:chebi>) </plain></SENT>
<SENT sid="3" pm="."><plain>These increased clotting times disappeared when anti-H1 monoclonal antibody (mAb) was added to the incubation </plain></SENT>
<SENT sid="4" pm="."><plain>Dilute Russell Viper Venom Time was also prolonged with the addition of <z:chebi fb="0" ids="15358">histone</z:chebi> H1 </plain></SENT>
<SENT sid="5" pm="."><plain>When H1 was added to plasma from a patient with the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APL plasma), there was a further prolongation of the abnormal APL clotting time which was partially corrected by anti-H1 mAb </plain></SENT>
<SENT sid="6" pm="."><plain>Platelet neutralization times were increased with added H1 and were further increased using APL plasma. when disrupted endothelial cells were incubated with plasma with and without anti-H1 antibodies, the addition of anti-H1 antibodies decreased clotting times </plain></SENT>
<SENT sid="7" pm="."><plain>These data support the theory that <z:chebi fb="0" ids="15358">histones</z:chebi> released during cell injury may have a regulatory <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> role in clot formation and the anti-H1 effect of some APL plasmas may inhibit this, thereby contributing to <z:mp ids='MP_0005048'>thrombosis</z:mp> seen in APL patients </plain></SENT>
</text></document>